The cognitive dissonance is strong on mainstream news these days.
CEOs are both championing cannabis as a exit from deadly opiate use, and celebrating an ‘oligopolist’ approach to continued prohibition. They’re eager to sell the benefits of clean, small batch cannabis, but also more than happy to run the mom and pop pioneers out of the industry under the guise of regulation.
Jim Cramer, professional loudmouth, isn’t much help.
Perhaps they all need a taste of their own medicine.